Jeffrey Molldrem
Keine laufenden Positionen mehr
Karriereverlauf von Jeffrey Molldrem
Ehemalige bekannte Positionen von Jeffrey Molldrem
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2003 | - |
Gründer | 01.11.2009 | - | |
Corporate Officer/Principal | 01.07.2003 | 01.11.2009 |
Ausbildung von Jeffrey Molldrem
University of Minnesota | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Jeffrey Molldrem
- Erfahrung